Fletcher Payne - Net Worth and Insider Trading

Fletcher Payne Net Worth

The estimated net worth of Fletcher Payne is at least $13,567 dollars as of 2024-05-21. Fletcher Payne is the CFO of Catalyst Biosciences Inc and owns about 1,669 shares of Catalyst Biosciences Inc (CBIO) stock worth over $12,800. Fletcher Payne is also the SR VP & Chief Fin. Officer of Aptose Biosciences Inc and owns about 667 shares of Aptose Biosciences Inc (APTO) stock worth over $767. Details can be seen in Fletcher Payne's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fletcher Payne has not made any transactions after 2022-09-19 and currently still holds the listed stock(s).

Transaction Summary of Fletcher Payne

To

Fletcher Payne Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fletcher Payne owns 2 companies in total, including Catalyst Biosciences Inc (CBIO) , and Aptose Biosciences Inc (APTO) .

Click here to see the complete history of Fletcher Payne’s form 4 insider trades.

Insider Ownership Summary of Fletcher Payne

Ticker Comapny Transaction Date Type of Owner
CBIO Catalyst Biosciences Inc 2018-01-12 Chief Financial Officer
APTO Aptose Biosciences Inc 2022-09-19 SR VP & Chief Fin. Officer

Fletcher Payne Latest Holdings Summary

Fletcher Payne currently owns a total of 2 stocks. Among these stocks, Fletcher Payne owns 1,669 shares of Catalyst Biosciences Inc (CBIO) as of December 17, 2015, with a value of $12,800 and a weighting of 94.35%. Fletcher Payne also owns 667 shares of Aptose Biosciences Inc (APTO) as of September 19, 2022, with a value of $767 and a weighting of 5.65%.

Latest Holdings of Fletcher Payne

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CBIO Catalyst Biosciences Inc 2015-12-17 1,669 7.67 12,800
APTO Aptose Biosciences Inc 2022-09-19 667 1.15 767

Holding Weightings of Fletcher Payne


Fletcher Payne Form 4 Trading Tracker

According to the SEC Form 4 filings, Fletcher Payne has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the acquisition of 667 shares on December 17, 2015, which cost Fletcher Payne around $20,000.

According to the SEC Form 4 filings, Fletcher Payne has made a total of 1 transactions in Aptose Biosciences Inc (APTO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aptose Biosciences Inc is the acquisition of 667 shares on September 19, 2022, which cost Fletcher Payne around $6,800.

Insider Trading History of Fletcher Payne

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fletcher Payne Trading Performance

GuruFocus tracks the stock performance after each of Fletcher Payne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fletcher Payne is -21.05%. GuruFocus also compares Fletcher Payne's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fletcher Payne within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Fletcher Payne's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Fletcher Payne

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.77
Relative Return to S&P 500(%) -1.19

Fletcher Payne Ownership Network

Ownership Network List of Fletcher Payne

No Data

Ownership Network Relation of Fletcher Payne


Fletcher Payne Owned Company Details

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Fletcher Payne is the Chief Financial Officer of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Biosciences Inc Insider Transactions

No Available Data

Fletcher Payne Mailing Address

Above is the net worth, insider trading, and ownership report for Fletcher Payne. You might contact Fletcher Payne via mailing address: 260 Littlefield Avenue, South San Francisco Ca 94080.

Discussions on Fletcher Payne

No discussions yet.